Samples and RNA sequencing
RNA sequencing was performed using 50 single embryos (Figure 1).
Figure 1. Experimental set-up for single embryo RNA-sequencing. The arrows indicate the between group analyses.
A total of 1,405 million raw reads was obtained after RNA sequencing, with a duplication rate of 63 ± 7% (mean ± SD) and a GC content of 45 ± 1% (mean ± SD). The mapping rate after quality filtering was 84 ± 6% (mean ± SD). The number of detected transcripts increased with developmental progression for the in vivo produced embryos, while it decreased for the in vitro produced embryos (Additional file 1). The low number of detected transcripts for the 4-cell in vivo embryos might be the consequence of analyzing early 4-cell embryos shortly after EGA combined with a relatively low input and cDNA yield during library preparation (Additional file 2). Given the uncertainty of the embryonic developmental stages of in vivo embryos, different RNA quality, and read alignment at the 4-cell, as well as at the morula stage (Additional file 2 and 3), the in vivo developed and in vitro produced embryos were analyzed separately and not compared to each other. To identify in vitro fertilization pipeline-induced transcriptome differences, the hatched blastocysts were used for an in vivo developed versus in vitro produced comparison.
Developmental transcriptome dynamics
To provide a developmental stage-specific overview, global developmental transcriptome dynamics were investigated. Principal component analyses (PCA) were performed separately for the in vivo developed and in vitro produced embryos and showed a clear developmental stage-specific clustering of the embryos (Figure 2A and B). For the in vivo developed embryos, PC1 and PC2 explained 77.8% and 11.4% of the variance in transcript levels. For the in vitro produced embryos, PC1 and PC2 explained 71.8% and 17.3% of the variance. The in vivo 4-cell embryos displayed a larger degree of transcriptional heterogeneity than the in vitro 4-cell embryos. The morulae and hatched blastocysts were sexed based on the expression of Y-chromosome specific transcripts. At the morula stage, male and female embryos clustered together, yet the clusters were not fully overlapping. At the blastocyst stages, the male and female clusters were fully overlapping.
Figure 2. Between-group analyses of the 4-cell stage embryos, morulae and hatched blastocysts of A. In vivo developed embryos, and B. In vitro produced embryos.
In vivo and in vitro embryonic developmental dynamics
The developmental transcriptome dynamics were further analyzed by identifying differentially expresses genes (DEGs) between the 4-cell and morula stage, and the morula and hatched blastocyst stage for both the in vivo developed and in vitro produced embryos. The number of DEGs was higher between the 4-cell to morula stage, than for the morula to hatched blastocyst stage (Figure 3). For the in vivo embryos, 10,089 and 2,347 DEGs were identified between the 4-cell to the morula stage and the morula stage to the hatched blastocyst stage, respectively (Figure 3A). For the in vitro embryos, 8,152 and 4,023 DEGs were identified between the 4-cell to the morula stage and the morula stage to the hatched blastocyst stage, respectively (Figure 3B).
Figure 3. Upset plot displaying the differentially expressed genes during embryo development from the 4-cell to the morula stage and the morula to the hatched blastocyst stage in A. In vivo developed embryos, and B. In vitro produced embryos.
The developmental dynamics were assessed with a self-organizing tree algorithm (Figure 4A and B). For both the in vivo and in vitro produced embryos, the detected transcript expression changed from the 4-cell to the morula stage. The transcripts in cluster 1 decreased from the 4-cell to the morula stage, and remained low at the hatched blastocyst stage. The transcripts in cluster 2 displayed a gradual increase with developmental progression. The transcripts in cluster 3 were increased at the morula stage, while remaining low at the 4-cell and the hatched blastocyst stage.
Figure 4. Transcriptome dynamics during development displayed by a self-organizing tree algorithm for A. In vivo developed embryos, and B.In vitro produced embryos. The number of genes per cluster and the embryonic sex of the morulae and hatched blastocysts are indicated.
Biological functions of embryonic developmental dynamics
To gain insight into the biological functions of the DEGs, a canonical pathway enrichment analysis was conducted (Figure 5). In both the in vivo and the in vitro produced 4-cell to morula stage embryos, there was a significant enrichment of oxidative phosphorylation, tRNA charging and EIF2 signaling. From the morula to the hatched blastocyst stage, the DEGs in the pathways 14-3-3-mediated signaling, signaling of Rho Family GTPases, and NRF2-mediated oxidative stress response were all higher expressed at the hatched blastocyst stage for both the in vivo and in vitro produced embryos.
Figure 5. Enriched canonical pathways. Red (-) dots represent canonical pathways of which genes were significantly lower expressed in the 4-cell versus morula and morula versus hatched blastocysts, and blue (+) represent canonical pathways of which genes were significantly higher expressed in the 4-cell versus morula or morula versus hatched blastocysts. The GeneRatio indicates the proportion of DEGs that were identified in an enriched canonical pathway. Shared enriched canonical pathways in both in vivo developed and in vitro produced embryos at the 4-cell versus morula or morula versus hatched blastocyst stage are indicated in purple.
The ERK/MAPK signaling pathway was significantly enriched in vivo at the 4-cell to morula transition, and was predicted to result in a lower rate of transcription at the 4-cell stage (Additional file 4). In the in vivo embryos, the TNFR1 signaling predicted a lower degree of apoptosis and cell survival at the 4-cell stage compared to morulae stage (Additional file 4). The in vivo hatched blastocysts displayed a significant enrichment of estrogen biosynthesis compared to the morulae stage (Additional file 4).
In vivo and in vitro differences at the hatched blastocyst stage
The in vivo and in vitro hatched blastocysts were compared, as the embryos displayed similar cDNA profiles, library smears and alignment coverages for the most abundant transcripts at this developmental stage (Additional file 2 and 3). Embryos at this stage of development are thought to be more alike than at earlier stages, as time differences related to fertilization at earlier stages contribute more substantially to the actual developmental stage.
At the hatched blastocyst stage, the selection of developmentally competent embryos has already taken place. Yet, we unraveled in vitro fertilization pipeline-induced sex-specific differences. The in vivo developed female and male hatched blastocysts clustered largely together (Figure 6A). They were separated from the in vitro hatched blastocyst in a sex-specific manner by principal component 1. While 33 DEGs were identified between the female in vivo and in vitro produced embryos, 241 DEGs were identified between the male in vivo and in vitro produced embryos. Figure 6B displays the difference between in vivo developed and in vitro produced embryos in a sex-independent manner. There were no DEGs when comparing male and female embryos for either in vivo developed or in vitro produced embryos. By comparing the female in vivo developed versus in vitro produced embryos, the DEGs inositol polyphosphate multikinase (IPMK) and Rac family small GTPase 1 (RAC1) were specific to this comparison. The other 31 DEGs were also discovered by comparing the in vivo and in vitro male hatched blastocysts. These genes were involved in amino acids transport, synthesis and metabolism, and similarly expressed in both female and male embryos (Figure 6C). Irrespective of the embryos’ sex, the in vivo embryos had a lower expression of genes involved in amino acid transport, synthesis and metabolism compared to the in vitro embryos. When disregarding the sex of the embryos and emphasizing on the embryo source, the persistent difference between in vivo developed and in vitro produced embryos at the hatched blastocyst stage were illustrated by an enrichment of five canonical pathways (Figure 6D). Except for a higher expression in in vivo versus in vitro hatched blastocysts of DEGs involved in cyclins and cell cycle regulation, the DEGs involved in tRNA charging, cell cycle: G1/S checkpoint regulation, PEDF signaling, and neuro-inflammation signaling pathway were higher expressed in in vitro than in in vivo hatched blastocysts. The PEDF signaling pathway was inhibited in in vivo hatched blastocysts compared to the in vitro hatched blastocysts and was predicted to result in a lower rate of apoptosis in in vivo hatched blastocysts (Additional file 4).
Figure 6. A. Between group analysis of in vivo and in vitro female and male hatched blastocysts, B. Heatmap displaying the 243 DEGs observed by comparing in vivo produced versus in vitro developed females and the in vivo produced versus in vitro developed males. C. Heatmap displaying genes involved in amino acid metabolism, and D. Significantly enriched canonical pathways between the in vivo developed and in vitro produced hatched blastocysts. Red (-) dots represent canonical pathways of which genes were significantly less expressed in the in vivo embryos, while blue (+) represent canonical pathways of which genes were significantly higher expressed in the in vivo embryos. The GeneRatio indicates the proportion of DEGs that were identified in an enriched canonical pathway.